NEW YORK, March 9 (Reuters) - Allergan Inc shares rose in extended trading on Tuesday after the U.S. Food and Drug Administration approved the use of Allergan's wrinkle smoother Botox to treat spasms of the elbow, wrist and fingers in adults. For details see.
Shares last traded up 3.5 percent at $63.50. Keywords: MARKETS STOCKS AFTERTHEBELL (rodrigo.campos@thomsonreuters.com; + 1 646-223-6344; Reuters Messaging: rodrigo.campos.reuters.com@reuters.net) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
Shares last traded up 3.5 percent at $63.50. Keywords: MARKETS STOCKS AFTERTHEBELL (rodrigo.campos@thomsonreuters.com; + 1 646-223-6344; Reuters Messaging: rodrigo.campos.reuters.com@reuters.net) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.